ARCHIVES

WHT Participants Get “Phase Out” Help

This article is from The Cancer Letter archive.

Vol. 14 No. 11 | March 11, 1988

Download PDF Visit The Full Archive

Related Articles

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

FDA Forms Office of Combination Products;

January 10, 2003

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

FDA, NCI Near Agreement On Handling INDs

January 28, 1977

Congress gives FDA authority to require pediatric clinical trials.

November 28, 2003

Tamoxifen Trial may EB Funded In Part With CCOP Money

March 22, 1991